Federal Register of Legislation - Australian Government

Primary content

Determinations/Health as made
This instrument amends the Health Insurance (Section 3C Pathology Services – COVID-19) Determination 2020 to remove a COVID-19 item from the pathology services table and replace it with 4 new items with higher fees including two items providing those higher fees to apply for services provided under the old item from 13 March 2020 to 31 March 2020 by creating a supplementary fee on which a benefit may be bulk billed.
Administered by: Health
Registered 31 Mar 2020
Tabling HistoryDate
Tabled HR08-Apr-2020
Tabled Senate08-Apr-2020
Date of repeal 01 Sep 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

Health Insurance (Section 3C Pathology Services – COVID-19) Amendment (No. 2) Determination 2020

I, DAVID WEISS, delegate of the Minister for Health, make the following determination

 

Dated                       31 March 2020

 

David Weiss

First Assistant Secretary

Medical Benefits Division

Health Financing Group

Department of Health

 

 

 


Contents

1.  Name....................................................................................................................................... 1

2.  Commencement....................................................................................................................... 1

3.  Amendment of Health Insurance (Section 3C Pathology Services – COVID‑19) Determination 2020             1

4.  Authority................................................................................................................................. 1

Schedule 1 – Amendment                                                                                             2

 

 


1.  Name

                        This instrument is the Health Insurance (Section 3C Pathology Services – COVID-19) Amendment (No. 2) Determination 2020

2.  Commencement

(1)   Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 April 2020

 

                Note:        This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)   Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3.  Amendment of Health Insurance (Section 3C Pathology Services – COVID‑19) Determination 2020

Schedule 1 amends the Health Insurance (Section 3C Pathology Services – COVID‑19) Determination 2020.

4.  Authority

                        This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

 

Schedule 1 – Amendment

[1]       Section 7

Revoke subsection (1) and substitute:

(1)     Clause 1.7 of the pathology services table shall have effect as if items 69476, 69477, 69479, 69480 of this Determination were specified in paragraph 1.7(2)(a) of the pathology services table.

(2)     Where a service is performed in circumstances described in item 69479 then item 69480 cannot be claimed.

[2]       Schedule 1 – relevant services

Revoke the table and substitute:

 

Group P3 – Microbiology  

 

Column 1

Column 2

Column 3

Item

Pathology service

Fee ($)

69476

Detection of a SARS-CoV-2 nucleic acid 1 or more tests if the service was bulk-billed between 13 March 2020 and 31 March 2020 where:

(a) the person was a private patient in a recognised hospital; or

(b) the person received the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table

Supplementary item in addition to item 69485

21.25

69477

Detection of a SARS-CoV-2 nucleic acid 1 or more tests if the service was bulk-billed between 13 March 2020 and 31 March 2020 where:

(a) the person was not a private patient in a recognised hospital; or

(b) the person did not receive the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table

Supplementary item in addition to item 69485

71.25

69479

 

Detection of a SARS-CoV-2 nucleic acid 1 or more tests if:

(a) the person is a private patient in a recognised hospital; or

(b) the person receives the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table

Where the service is bulk-billed.

50.00

69480

Detection of a SARS-CoV-2 nucleic acid 1 or more tests if:

(a) the service is not covered by item 69479

Where the service is bulk billed

100.00

Note: The payments mentioned in Column 3 for items 69476 and 69477 are additional payments for providing SARS-COV-2 testing under previous item 69485 during the time period mentioned in Column 2.